Exsulin's Convertible Note Round

Exsulin raised a round of funding on February 09, 2009. Investors include Origin Partners.

Exsulin is aimed at correcting an underlying cause of diabetes - the loss of insulin producing islets - and is expected to offer Type 1 diabetes patients a path toward improving or normalizing glucose…

Articles about Exsulin's Convertible Note Round: